SciSafe acquired and invested by 1315 Capital for expansion of biostorage solutions
Acquiring Company
1315 Capital
Acquired Company
SciSafe Inc.
PhiladelphiaCranburyBiotechnologyHealth CareVenture CapitalMedicalBiotechnologyDescription
SciSafe, a leading provider of biological and pharmaceutical storage services, has announced its acquisition and growth capital investment by 1315 Capital, a Philadelphia-based growth equity firm. With this acquisition, SciSafe is established as a standalone business and will focus on expanding its customized and comprehensive biostorage solutions. Garrie Richardson, founder and former CEO of SciSafe, is rejoining the company as CEO and board member with the transaction, expressing excitement about the partnership and expansion plans.
Quick answer
1315 Capital is acquiring SciSafe Inc., announced November 14, 2024. 1315 Capital is based in Philadelphia, Pennsylvania, United States.
- Who acquired SciSafe Inc?
- 1315 Capital agreed to acquire SciSafe Inc. on November 14, 2024.
- How much did 1315 Capital pay for SciSafe Inc?
- The deal value was not disclosed.
- What does 1315 Capital do?
- 1315 Capital provides expansion and growth capital to commercial-stage healthcare services, medical technology, medtech & pharma outsourcing, and health & wellness companies.
- Where are 1315 Capital and SciSafe Inc. based?
- 1315 Capital is based in Philadelphia, Pennsylvania, United States. SciSafe Inc. is based in Cranbury, New Jersey, United States.
- Who are the decision-makers at 1315 Capital?
- Fundz holds 1 contact at 1315 Capital. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Venture Capital and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation (November 15, 2024)
- OraSure Technologies completes acquisition of Sherlock Biosciences, Inc. to expand its innovation pipeline in molecular testing market (December 19, 2024)
- Novo Holdings completes acquisition of Catalent, Inc. (December 18, 2024)
- Medtronic completes acquisition of Fortimedix to enhance its surgical technology portfolio (November 22, 2024)
- Flashpoint Therapeutics announces $50M Partnership with KAIMRC and Clinical Pipeline Expansion (November 14, 2024)
- Organon successfully acquires Dermavant Sciences Ltd. to expand dermatology portfolio (October 28, 2024)
Who to call at 1315 Capital, and when
When 1315 Capital changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day 1315 Capital raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at 1315 Capital, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at 1315 Capital. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment 1315 Capital makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired SciSafe Inc.?
SciSafe Inc. was acquired by 1315 Capital, based in Philadelphia. The deal was reported on November 14, 2024. 1315 Capital provides expansion and growth capital to commercial-stage healthcare services, medical technology, medtech & pharma outsourcing, and health & wellness companies. 1315 Capital is privately held and operates in Biotechnology.
When did 1315 Capital acquire SciSafe Inc.?
1315 Capital's acquisition of SciSafe Inc. was reported on November 14, 2024. SciSafe, a leading provider of biological and pharmaceutical storage services, has announced its acquisition and growth capital investment by 1315 Capital, a Philadelphia-based growth equity firm. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does SciSafe Inc. do?
SciSafe, a leading provider of biological and pharmaceutical storage services, is a cGMP-compliant provider of specialized storage and cold chain management solutions for biopharmaceutical and pharmaceutical companies. It is privately held, operating in Biotechnology, and is based in Cranbury.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.